Axis Bio is a preclinical contract research organisation with specialist capabilities in oncology, inflammation and respiratory diseases.
Services range from in vitro efficacy and mechanistic studies, to in vivo target engagement, with each study tailored to the unique requirements of the client.
Our clients are spread across the globe and include pharmaceutical and biotech businesses, university-based research organisations and virtual/semi-virtual development companies.
We listen, guide and advise clients through every step of the preclinical efficacy testing process, to deliver clear and robust results in a timely and cost-effective manner. This approach applies whether we are simply carrying out the in-life phase of a study or providing a complete package of analysis including FACS, bioanalysis and blood analysis, along with a detailed interpretation of results and recommendations.